IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2004;45:2293-2298.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0958

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jabs, D. A.
Right arrow Articles by Whittum-Hudson, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jabs, D. A.
Right arrow Articles by Whittum-Hudson, J. A.

Inflammatory Mediators in Autoimmune Lacrimal Gland Disease in MRL/Mpj Mice

Douglas A. Jabs,1,2,3 Hérvé C. Gérard,4 Yuewang Wei,5 Adam L. Campbell,5 Alan P. Hudson,4 Esen Karamursel Akpek,1 Bella Lee,1 Robert A. Prendergast,1 and Judith A. Whittum-Hudson4,5,6

1From the Departments of Ophthalmology and 2Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 3The Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; and the 4Departments of Immunology and Microbiology, 5Medicine, and 6Ophthalmology, Wayne State University, Detroit, Michigan.

PURPOSE. MRL/MpJ-fas+/fas+ (MRL/+) and MRL/MpJ-faslpr/faslpr (MRL/lpr) mice are congenic substrains of mice that have spontaneously developing lacrimal and salivary gland inflammation and are models for the human disorder Sjögren’s syndrome. Nitric oxide (NO) and tumor necrosis factor (TNF)-{alpha} are proinflammatory and potential mediators of tissue damage. The presence of the inducible form of nitric oxide synthase (iNOS), which catalyzes the production of NO, and the presence TNF-{alpha} in the lacrimal glands of MRL/MpJ mice were assessed.

METHODS. Lacrimal glands from MRL/+ and MRL/lpr mice, at ages 1 through 9 months, were evaluated by real-time RT-PCR for iNOS and TNF-{alpha} mRNA and by immunohistochemistry for the presence of iNOS and of TNF-{alpha}. Age-matched BALB/c lacrimal glands were used as the control.

RESULTS. By quantitative real-time PCR (qPCR), mRNA for iNOS was detected in the lacrimal glands in significantly greater amounts in both MRL/+ (median, normalized to 18S rRNA, 2.90; P < 0.0003) and MRL/lpr mice (median 6.84, P < 0.001) than in BALB/c mice (median 0.34). By qPCR, mRNA for TNF-{alpha} in the lacrimal glands was detected in significantly greater amounts in aged MRL/+ mice than in BALB/c mice (median, normalized to actin, 221.8 vs. 77.8, P = 0.011) and in MRL/lpr mice than in BALB/c mice (median 136.7 vs. 72.5, P = 0.001). Immunohistochemistry demonstrated both iNOS and TNF-{alpha} in scattered mononuclear cells throughout the lacrimal glands and in mononuclear cells at the junction of the focal inflammatory infiltrates and normal acinar tissue in both MRL/+ and MRL/lpr mice.

CONCLUSIONS. As demonstrated by the greater presence of iNOS and TNF-{alpha} in the lacrimal glands of MRL/MpJ mice than in control glands, both NO and TNF-{alpha} are potential mediators of lacrimal gland damage in these murine models of Sjögren’s syndrome.





This article has been cited by other articles:


Home page
IOVSHome page
D. A. Jabs, R. A. Prendergast, A. L. Campbell, B. Lee, E. K. Akpek, H. C. Gerard, A. P. Hudson, and J. A. Whittum-Hudson
Autoimmune Th2-Mediated Dacryoadenitis in MRL/MpJ Mice Becomes Th1-Mediated in IL-4 Deficient MRL/MpJ Mice
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5624 - 5629.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology